Michael K. Ahlijanian

6.3k total citations · 1 hit paper
59 papers, 4.5k citations indexed

About

Michael K. Ahlijanian is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Michael K. Ahlijanian has authored 59 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 27 papers in Cellular and Molecular Neuroscience and 21 papers in Physiology. Recurrent topics in Michael K. Ahlijanian's work include Neuroscience and Neuropharmacology Research (22 papers), Alzheimer's disease research and treatments (17 papers) and Ion channel regulation and function (13 papers). Michael K. Ahlijanian is often cited by papers focused on Neuroscience and Neuropharmacology Research (22 papers), Alzheimer's disease research and treatments (17 papers) and Ion channel regulation and function (13 papers). Michael K. Ahlijanian collaborates with scholars based in United States, United Kingdom and Sweden. Michael K. Ahlijanian's co-authors include William A. Catterall, Ruth E. Westenbroek, W A Catterall, Johannes Hell, R. Westenbroek, T P Snutch, Mary Gilbert, A.E. Takemori, Dermot M.F. Cooper and Shih-Chu Kao and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael K. Ahlijanian

58 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits.

1993 640 citations Michael K. Ahlijanian, William A. Catterall et al. The Journal of Cell Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael K. Ahlijanian United States	30	2.7k	2.2k	1.5k	444	432	59	4.5k
Peter H. Reinhart United States	34	2.6k 1.0×	1.8k 0.8×	1.5k 1.0×	245 0.6×	420 1.0×	64	4.7k
Ratan V. Bhat United States	32	3.1k 1.1×	2.0k 0.9×	1.3k 0.9×	498 1.1×	636 1.5×	47	5.4k
Inger Lauritzen France	33	2.7k 1.0×	1.6k 0.7×	1.2k 0.8×	545 1.2×	309 0.7×	47	4.5k
SH Snyder United States	26	2.5k 0.9×	2.9k 1.3×	1.2k 0.8×	261 0.6×	167 0.4×	28	5.0k
Aline Dumuis France	54	5.0k 1.8×	5.2k 2.3×	891 0.6×	337 0.8×	651 1.5×	98	7.7k
Alain Buisson France	41	1.8k 0.7×	2.0k 0.9×	1.6k 1.1×	337 0.8×	340 0.8×	79	5.2k
Jesús Gomeza Germany	43	4.0k 1.5×	4.0k 1.8×	713 0.5×	312 0.7×	306 0.7×	65	5.8k
Fang Cai China	32	1.8k 0.7×	905 0.4×	1.7k 1.2×	348 0.8×	427 1.0×	91	4.2k
Mark L. Dell’Acqua United States	42	4.1k 1.5×	3.0k 1.4×	620 0.4×	667 1.5×	216 0.5×	89	5.8k
Guy R. Seabrook United States	41	2.8k 1.0×	4.0k 1.8×	2.3k 1.6×	295 0.7×	763 1.8×	88	6.3k

Countries citing papers authored by Michael K. Ahlijanian

Since Specialization

Citations

This map shows the geographic impact of Michael K. Ahlijanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael K. Ahlijanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael K. Ahlijanian more than expected).

Fields of papers citing papers by Michael K. Ahlijanian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael K. Ahlijanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael K. Ahlijanian. The network helps show where Michael K. Ahlijanian may publish in the future.

Co-authorship network of co-authors of Michael K. Ahlijanian

This figure shows the co-authorship network connecting the top 25 collaborators of Michael K. Ahlijanian. A scholar is included among the top collaborators of Michael K. Ahlijanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael K. Ahlijanian. Michael K. Ahlijanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shin, Samuel S., Andrea L.C. Schneider, Sarah U. Morton, et al.. (2023). Exploring the Therapeutic Potential of Phosphorylated Cis-Tau Antibody in a Pig Model of Traumatic Brain Injury. Biomedicines. 11(7). 1807–1807. 4 indexed citations

Qureshi, Irfan, Giridhar Tirucherai, Michael K. Ahlijanian, et al.. (2018). A randomized, single ascending dose study of intravenous BIIB092 in healthy participants. Alzheimer s & Dementia Translational Research & Clinical Interventions. 4(1). 746–755. 69 indexed citations

Rajamani, Ramkumar, Mian Gao, Simon Low, et al.. (2017). A Functional NaV1.7-NaVAb Chimera with a Reconstituted High-Affinity ProTx-II Binding Site. Molecular Pharmacology. 92(3). 310–317. 11 indexed citations

Robertson, Alan S., Lawrence G. Iben, Cong Wei, et al.. (2017). Synergistic inhibition of Aβ production by combinations of γ-secretase modulators. European Journal of Pharmacology. 812. 104–112. 3 indexed citations

Wu, Yong‐Jin, Ramkumar Rajamani, Jeremy H. Toyn, et al.. (2016). Discovery of furo[2,3-d][1,3]thiazinamines as beta amyloid cleaving enzyme-1 (BACE1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(23). 5729–5731. 14 indexed citations

Sivarao, Digavalli V., Ping Chen, Arun Senapati, et al.. (2016). 40 Hz Auditory Steady-State Response Is a Pharmacodynamic Biomarker for Cortical NMDA Receptors. Neuropsychopharmacology. 41(9). 2232–2240. 100 indexed citations

Jacobsen, Leslie K., Clifford Bechtold, Giridhar Tirucherai, Michael K. Ahlijanian, & Feng Luo. (2016). BMS-986089: A novel adnectin protein that dose dependently lowers free myostatin and increases muscle volume and lean body mass. Neuromuscular Disorders. 26. S95–S95. 6 indexed citations

Wu, Yong‐Jin, Fukang Yang, Lawrence B. Snyder, et al.. (2016). Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents. ACS Medicinal Chemistry Letters. 7(3). 271–276. 22 indexed citations

Toyn, Jeremy H. & Michael K. Ahlijanian. (2014). Interpreting Alzheimer’s disease clinical trials in light of the effects on amyloid-β. Alzheimer s Research & Therapy. 6(2). 14–14. 20 indexed citations

10.

Sivarao, Digavalli V., Ping Chen, Yili Yang, et al.. (2014). NR2B Antagonist CP-101,606 Abolishes Pitch-Mediated Deviance Detection in Awake Rats. Frontiers in Psychiatry. 5. 96–96. 35 indexed citations

11.

Meredith, Jere E., Sethu Sankaranarayanan, Valerie Guss, et al.. (2013). Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease. PLoS ONE. 8(10). e76523–e76523. 152 indexed citations

12.

Helal, Christopher J., Zhijun Kang, Thomas G. Gant, et al.. (2009). Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters. 19(19). 5703–5707. 40 indexed citations

13.

Patzke, Holger, Richard Chesworth, Jessica Smith, et al.. (2008). Discovery and Development of Novel HDAC Inhibitors for Huntington’s Disease. Neurotherapeutics. 5(2). 371–371. 1 indexed citations

14.

Noble, Wendy, Vicki Olm, Kazuyuki Takata, et al.. (2003). Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo. Neuron. 38(4). 555–565. 405 indexed citations

15.

Kao, Shih-Chu, Cynthia A. Lemere, Weiming Xia, et al.. (2003). APP processing is regulated by cytoplasmic phosphorylation. The Journal of Cell Biology. 163(1). 83–95. 366 indexed citations

16.

Lau, Lit‐Fui & Michael K. Ahlijanian. (2003). Role of cdk5 in the Pathogenesis of Alzheimer’s Disease. Neurosignals. 12(4-5). 209–214. 54 indexed citations

17.

Ahlijanian, Michael K., Ruth E. Westenbroek, & William A. Catterall. (1990). Subunit structure and localization of dihydropyridine-sensitive calcium channels in mammalian brain, spinal cord, and retina. Neuron. 4(6). 819–832. 236 indexed citations

18.

Ahlijanian, Michael K. & Dermot M.F. Cooper. (1988). Distinct interactions between Ca2+/calmodulin and neurotransmitter stimulation of adenylate cyclase in striatum and hippocampus. Cellular and Molecular Neurobiology. 8(4). 459–469. 22 indexed citations

19.

Cooper, Dermot M.F., et al.. (1986). Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.. Molecular Pharmacology. 29(2). 113–119. 67 indexed citations

20.

Ahlijanian, Michael K. & A.E. Takemori. (1986). Effects of caffeine and 8-phenyltheophylline on the actions of purines and opiates in the guinea-pig ileum.. Journal of Pharmacology and Experimental Therapeutics. 236(1). 171–176. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact